Back to Journals » Lung Cancer: Targets and Therapy » Volume 15

Commentary

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?

       
Total article views   HTML views PDF downloads Totals
1,016 Dovepress* 1,016+ 18 1,034
Totals 1,016 18 1,034
*Since 12 April 2024

View citations on PubMed Central and Google Scholar